Macedonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
11 резултати
Method for treatment of cancer by oral administration of modified pectin
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
FIELD OF THE INVENTION
The present invention relates generally to methods for treating prostate cancer.
BACKGROUND OF THE INVENTION
The incidence of many forms of cancer is expected to increase as the population ages. For example, prostate cancer is the most commonly diagnosed cancer in United
Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
FIELD OF THE INVENTION
The present invention relates generally to methods for treating prostate cancer.
BACKGROUND OF THE INVENTION
The incidence of many forms of cancer is expected to increase as the population ages. For example, prostate cancer is the most commonly diagnosed cancer in United
Synergistic combination of honokiol and modified citrus pectin in cancer therapy
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to regimens and therapeutics intended to inhibit the formation, progression and metastatic conversion of a variety of cancers in mammals, including humans. Cancers effectively targeted by this regimen include solid
Pectic enzyme treated pectin, method of producing the same and application thereof
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
RELATED APPLICATIONS
This application claims priority to Taiwan Application Serial Number 100141068, filed on Nov. 10, 2011, which is herein incorporated by reference.
BACKGROUND
1. Field of Invention
The present invention relates to a pectic enzyme treated pectin (PET-pectin) and a method of
Binding of galectin-3 by low molecular weight pectin
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Binding of galectin-3 by low molecular weight pectin
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Binding of galectin-3 by low molecular weight pectin
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Methods for treating mammals with modified alginates and pectins
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to compositions, and methods of using the same, to protect mammals from, and treat mammals with diseases and conditions, mediated by various agents, including disease agents, heavy metals and other substances that can be
Reduction of galectin-3 levels by plasmapheresis
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
PRIORITY DATA AND INCORPORATION BY REFERENCE
This application claims benefit of priority to U.S. Provisional Patent Application No. 61/568,210 filed Dec. 8, 2011 which is incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention pertains to
Galectin-3 plasmapheresis therapy
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate
Galectin-3 plasmapheresis therapy
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate
Најкомплетната база на податоци за лековити билки поддржана од науката
- Работи на 55 јазици
- Лекови од билки поддржани од науката
- Препознавање на билки по слика
- Интерактивна GPS мапа - означете ги билките на локацијата (наскоро)
- Прочитајте научни публикации поврзани со вашето пребарување
- Пребарувајте лековити билки според нивните ефекти
- Организирајте ги вашите интереси и останете во тек со истражувањето на новостите, клиничките испитувања и патентите
Напишете симптом или болест и прочитајте за билки што можат да помогнат, напишете билка и видете болести и симптоми против кои се користи.
* Сите информации се базираат на објавени научни истражувања
